Evidence-Based Medicine Guidelines
Lipid-lowering efficacy of rosuvastatin
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lipid-lowering Efficacy of Rosuvastatin." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/Lipid_lowering_efficacy_of_rosuvastatin.
Lipid-lowering efficacy of rosuvastatin. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/Lipid_lowering_efficacy_of_rosuvastatin. Accessed November 29, 2023.
Lipid-lowering efficacy of rosuvastatin. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/Lipid_lowering_efficacy_of_rosuvastatin
Lipid-lowering Efficacy of Rosuvastatin [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/Lipid_lowering_efficacy_of_rosuvastatin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lipid-lowering efficacy of rosuvastatin
ID - 458368
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458368/all/Lipid_lowering_efficacy_of_rosuvastatin
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
